Since ancient times people have been searching for the secret of immortality. Their quest has always been, without exception, about a physical item: a fountain, an elixir, an Alchemist’s remedy, a chalice, a pill, an injection of stem cells or a vial containing gene-repairing material. It has never been about an abstract concept.
Our inability to find a physical cure for ageing is explained by a simple fact: We cannot find it because it does not exist. It will never exist.
Those who believe that someday some guy is going to discover a pill or a remedy and give it to people so that we will all live forever are, regrettably, deluded.
I should highlight here that I refer to a cure for the ageing process in general, and not a cure for a specific medical disease. Biotechnology and other physical therapies are useful in alleviating many diseases and ailments, but these therapies will not be the answer to the basic biological process of ageing.
In a paper I published in the journal Rejuvenation Research I outline some of the reasons why I think biotechnology will not solve the ageing problem. I criticise projects such as SENS (which are based upon physical repairs of our ageing tissues) as being essentially useless against ageing. The editor’s rebuttal (being weak and mostly irrelevant) proved and strengthened my point. There are insurmountable basic psychological, anatomical, biological and evolutionary reasons why physical therapies against ageing will not work and will be unusable by the general public. Some of these reasons include pleiotropy, non-compliance, topological properties of cellular networks, non-linearity, strategic logistics, polypharmacy and tolerance, etc. etc.
So, am I claiming that we are doomed to live a life of age-related pathology and degeneration, and never be able to shake off the aging curse? No, far from it. I am claiming that it is quite possible, even inevitable, that ageing will be eliminated but this will not be achieved through a physical intervention based on bio-medicine or bio-technology. Ageing will be eliminated through fundamental evolutionary and adaptation mechanisms, and this process will take place independently of whether we want it or not.
It works like this: We now age and die because we become unable to repair random background damage to our tissues. Resources necessary for this have been allocated by the evolutionary process to our germ cell DNA (in order to assure the survival of the species) and have been taken away from our bodily cells. Until now, our environment was so full of dangers that it was more thermodynamically advantageous for nature to maintain us up to a certain age, until we have progeny and then die, allowing our progeny to continue life.
However, this is now changing. Our environment is becoming increasingly more secure and protective. Our technology protects us against dangers such as infections, famine and accidents. We become increasingly embedded into the network of a global techno-cultural society which depends upon our intelligence in order to survive. There will come a time when biological resources spent to bring up children would be better spent in protecting us instead, because it would be more economical for nature to maintain an existing, well-embedded human, rather than allow it to die and create a new one who would then need more resources in order to re-engage with the techno-cultural network. Disturbing the network by taking away its constituents and trying to re-engage new inexperienced ones is not an ideal action and therefore it will not be selected by evolution.
The message is clear: You have more chances of defying ageing if, instead of waiting for someone to discover a pill to make you live longer, you become a useful part of a wider network and engage with a technological society. The evolutionary process will then ensure that you live longer-as long as you are useful to the whole.
Further reading http://ieet.org/index.php/IEET/more/kyriazis20121031 https://lifeboat.com/blog/2013/12/the-seven-fallacies-of-aging https://lifeboat.com/blog/2013/04/the-life-extension-hubris-why-biotechnology-is-unlikely-to-be-the-answer-to-ageing http://www.ncbi.nlm.nih.gov/pubmed/25072550 http://arxiv.org/abs/1402.6910
Since the first modern Olympic Games bowed in Athens in 1896, humanity has gradually integrated the developments of science and technology into the realm of competitive sport.
The various attempts to slow the utilization of advanced materials, pharmaceuticals, biotechnology, and robotics is akin to keeping certain gender or ethnic groups out of the games. Not just discrimination, but impeding the flow of progress.
If the ultimate goal of world-level competition is advancement of human physical ability, then athletes, coaches, physicians, and biotech engineers should be able to choose the very best tactics and strategies to achieve that goal.
A Transhuman Olympics would be wildly entertaining, but would also spur the development of biotechnology at a pace that public and private science could never keep up with. While the ethics of such an event might be hotly contested, the benefits to humankind would be lasting and far reaching.
Competitors involved would sign a medical waiver and hold harmless agreement. Education for both athletes and trainers would be mandatory so that participants and competitors understand the risks. Athletes in particular would have to attest that they are willingly participating in the games and that at the time of their consent to do so, they were of sound mind.
Performance enhancing substances — anabolic steroids, human growth hormones — would be permitted. Safer formulations would be encouraged. Experimentation would also be encouraged, insofar as it would drive the development of substances with less extreme, more commercial applications, outside of the games.
Biotechnology augmentation and bioengineered device integration would also be advised. Biotech is still in its relative infancy and the mainstream medical benefit for technology spun-off from this kind of competitive arena would be amazingly valuable.
In short, virtually any edge that provides enhanced performance times, distances, heights, or otherwise advances human competitive ability — be it mechanical, pharmaceutical, biotechnological, or genetic — would be considered fair game.
Boredom and sport would never again occur together in the same sentence. The performance-enhancing scandal that supposedly hurt the image of baseball in the late 1990s, led to new records from players like Mark McGwire, Sammy Sosa, and Roger Clemens, as well as a substantial lift in audience attention at the world level.
Some of the most competitive and gifted athletes in baseball watched as their reputations were dragged through the proverbial mud, as members of US Congress and the Federal judiciary presided over efforts to jail both trainers and athletes alike.
In reality, the use of performance enhancing substances in baseball goes back to 1889, when pitcher Pud Galvin used, and vocally endorsed, Brown-Séquard Elixir, a monkey-sourced testosterone supplement.
“Doping,” as it is commonly referred to, remains an American taboo subject.
The Transhuman Olympics would provide a venue for science to be more competitive and for athletes and trainers to take measures that they deem befitting to secure the best performance results.
Rather than laboratory-based timelines — often handled in academic settings, with limited access to financial resources — scientific improvements would need to find practical applications in the real world. Research efforts would have to provide meaningful, actionable improvements to athletic performance, within real world timeframes.
Imagine for a moment the incredible entertainment value. Perhaps countries with the most money just emerge victorious. Perhaps smaller scientific efforts with less access to resources would be forced to find novel innovations to gain a competitive advantage.
Watching athletes push the limits of humanity to achieve new records and break through established competitive plateaus is a fundamental facet of human evolution. The Transhuman Olympics would simply better facilitate that process.
Over time, the opportunity to invent new sports based on emerging capabilities and new technological developments would emerge. When the 1896 Olympics revived the ancient Olympic tradition, only one sport was excluded from the games (for you history buffs, the sport was pankration, a mild mixed martial art). However, with new technology and advanced human capability comes new competitive territory. Imagine a real-life Icarus competing with other airborne humans. Underwater games or sports in low-Earth orbit — the competitive horizon is endless.
Robotic elements, like chaser drones, helping athletes to see around corners or from other perspectives would be spectacular. Imagine force multipliers to provide boosts of strength or improve the strength and resilience of joints, muscles, tendons, and/or ligaments.
Once tested and proven in the venue of competitive sport, these technologies would have the widespread potential for mainstream medical adoption. Think of elderly patients who have trouble walking or individuals dealing with neurodegenerative disorders, now empowered thanks to the sacrifices and risks taken on by these gladiators of evolved sport.
Until modern society overcomes its resistance to unencumbered, more loosely regulated sporting events, the Transhuman Olympics would need to be held in a country with fewer controlled substance laws.
This country would likely receive a substantial windfall of medical tourism, so long as the technology being utilized was also developed there. Cuba springs first to mind but other present-day medical tourism destinations include Argentina, Brunei, Jordan, South Africa, Singapore, New Zealand and many others.
In modern Olympic competition, corporate sponsorship was first forbidden.
It wasn’t until 1972, when the medium of television opened up new channels for advertising, that corporate sponsorship began to emerge. In the Transhuman Olympics, corporate and/or government sponsorship would be essential and robustly encouraged.
With each passing Olympic games, the amount spent increases dramatically. Russia spent $51 billion on the 2014 games in Sochi, in the hopes of capturing and drawing the international spotlight.
In the Transhuman Olympics, the core benefits would include not only spectators and advertising sponsors, but tangible medical advancements and beneficial intellectual property.
We’re already living in the age of the technologically enhanced athlete.
LZR Racer swimsuits, made of woven elastane-nylon and buoyant polyurethane provided swimmers the ability to shave relatively substantial amounts of time from races. Those suits were banned in 2010, following the 2008 Beijing games.
The 1936 Olympics in Berlin showed Hitler that preconceived notions of superiority were no match for the power of diversity.
In 2012, for the first time since the inception of the International Olympic Committee, all countries participating in the Olympics sent delegations that included both male and female competitors. That same year, 204 countries sent competitors to the games.
Now that the human race has achieved an even playing field for global competition, the next step is technologically empowered, superhuman competitors.
Kindly join me in supporting the call for a Transhuman Olympics.
In this essay I argue that technologies and techniques used and developed in the fields of Synthetic Ion Channels and Ion Channel Reconstitution, which have emerged from the fields of supramolecular chemistry and bio-organic chemistry throughout the past 4 decades, can be applied towards the purpose of gradual cellular (and particularly neuronal) replacement to create a new interdisciplinary field that applies such techniques and technologies towards the goal of the indefinite functional restoration of cellular mechanisms and systems, as opposed to their current proposed use of aiding in the elucidation of cellular mechanisms and their underlying principles, and as biosensors.
In earlier essays (see here and here) I identified approaches to the synthesis of non-biological functional equivalents of neuronal components (i.e. ion-channels ion-pumps and membrane sections) and their sectional integration with the existing biological neuron — a sort of “physical” emulation if you will. It has only recently come to my attention that there is an existing field emerging from supramolecular and bio-organic chemistry centered around the design, synthesis, and incorporation/integration of both synthetic/artificial ion channels and artificial bilipid membranes (i.e. lipid bilayer). The potential uses for such channels commonly listed in the literature have nothing to do with life-extension however, and the field is to my knowledge yet to envision the use of replacing our existing neuronal components as they degrade (or before they are able to), rather seeing such uses as aiding in the elucidation of cellular operations and mechanisms and as biosensors. I argue here that the very technologies and techniques that constitute the field (Synthetic Ion-Channels & Ion-Channel/Membrane Reconstitution) can be used towards the purpose of the indefinite-longevity and life-extension through the iterative replacement of cellular constituents (particularly the components comprising our neurons – ion-channels, ion-pumps, sections of bi-lipid membrane, etc.) so as to negate the molecular degradation they would have otherwise eventually undergone.
While I envisioned an electro-mechanical-systems approach in my earlier essays, the field of Synthetic Ion-Channels from the start in the early 70’s applied a molecular approach to the problem of designing molecular systems that produce certain functions according to their chemical composition or structure. Note that this approach corresponds to (or can be categorized under) the passive-physicalist sub-approach of the physicalist-functionalist approach (the broad approach overlying all varieties of physically-embodied, “prosthetic” neuronal functional replication) identified in an earlier essay.
The field of synthetic ion channels is also referred to as ion-channel reconstitution, which designates “the solubilization of the membrane, the isolation of the channel protein from the other membrane constituents and the reintroduction of that protein into some form of artificial membrane system that facilitates the measurement of channel function,” and more broadly denotes “the [general] study of ion channel function and can be used to describe the incorporation of intact membrane vesicles, including the protein of interest, into artificial membrane systems that allow the properties of the channel to be investigated” . The field has been active since the 1970s, with experimental successes in the incorporation of functioning synthetic ion channels into biological bilipid membranes and artificial membranes dissimilar in molecular composition and structure to biological analogues underlying supramolecular interactions, ion selectivity and permeability throughout the 1980’s, 1990’s and 2000’s. The relevant literature suggests that their proposed use has thus far been limited to the elucidation of ion-channel function and operation, the investigation of their functional and biophysical properties, and in lesser degree for the purpose of “in-vitro sensing devices to detect the presence of physiologically-active substances including antiseptics, antibiotics, neurotransmitters, and others” through the “… transduction of bioelectrical and biochemical events into measurable electrical signals” .
Thus my proposal of gradually integrating artificial ion-channels and/or artificial membrane sections for the purpse of indefinite longevity (that is, their use in replacing existing biological neurons towards the aim of gradual substrate replacement, or indeed even in the alternative use of constructing artificial neurons to, rather than replace existing biological neurons, become integrated with existing biological neural networks towards the aim of intelligence amplification and augmentation while assuming functional and experiential continuity with our existing biological nervous system) appears to be novel, while the notion of artificial ion-channels and neuronal membrane systems ion general had already been conceived (and successfully created/experimentally-verified, though presumably not integrated in-vivo).
The field of Functionally-Restorative Medicine (and the orphan sub-field of whole-brain-gradual-substrate-replacement, or “physically-embodied” brain-emulation if you like) can take advantage of the decades of experimental progress in this field, incorporating both the technological and methodological infrastructures used in and underlying the field of Ion-Channel Reconstitution and Synthetic/Artificial Ion Channels & Membrane-Systems (and the technologies and methodologies underlying their corresponding experimental-verification and incorporation techniques) for the purpose of indefinite functional restoration via the gradual and iterative replacement of neuronal components (including sections of bilipid membrane, ion channels and ion pumps) by MEMS (micro-electrocal-mechanical-systems) or more likely NEMS (nano-electro-mechanical systems).
The technological and methodological infrastructure underlying this field can be utilized for both the creation of artificial neurons and for the artificial synthesis of normative biological neurons. Much work in the field required artificially synthesizing cellular components (e.g. bilipid membranes) with structural and functional properties as similar to normative biological cells as possible, so that the alternative designs (i.e. dissimilar to the normal structural and functional modalities of biological cells or cellular components) and how they affect and elucidate cellular properties, could be effectively tested. The iterative replacement of either single neurons, or the sectional replacement of neurons with synthesized cellular components (including sections of the bi-lipid membrane, voltage-dependent ion-channels, ligand-dependent ion channels, ion pumps, etc.) is made possible by the large body of work already done in the field. Consequently the technological, methodological and experimental infrastructures developed for the fields of Synthetic
Ion-Channels and Ion-Channel/Artificial-Membrane-Reconstitution can be utilized for the purpose of a.) iterative replacement and cellular upkeep via biological analogues (or not differing significantly in structure or functional & operational modality to their normal biological counterparts) and/or b.) iterative replacement with non-biological analogues of alternate structural and/or functional modalities.
Rather than sensing when a given component degrades and then replacing it with an artificially-synthesized biological or non-biological analogue, it appears to be much more efficient to determine the projected time it takes for a given component to degrade or otherwise lose functionality, and simply automate the iterative replacement in this fashion, without providing in-vivo systems for detecting molecular or structural degradation. This would allow us to achieve both experimental and pragmatic success in such cellular-prosthesis sooner, because it doesn’t rely on the complex technological and methodological infrastructure underlying in-vivo sensing, especially on the scale of single neuron components like ion-channels, and without causing operational or functional distortion to the components being sensed.
A survey of progress in the field  lists several broad design motifs. I will first list the deign motifs falling within the scope of the survey, and the examples it provides. Selections from both papers are meant to show the depth and breadth of the field, rather than to elucidate the specific chemical or kinetic operations under the purview of each design-variety.
For a much more comprehensive, interactive bibliography of papers falling within the field of Synthetic Ion-Channels or constituting the historical foundations of the field, see Jon Chui’s online biography here, which charts the developments in this field up until 2011.
Unimolecular ion channels:
Examples include a.) synthetic ion channels with oligocrown ionophores,  b.) using a-helical peptide scaffolds and rigid push–pull p-octiphenyl scaffolds for the recognition of polarized membranes,  and c.) modified varieties of the b-helical scaffold of gramicidin A 
Examples of this general class falling include avoltage-gated synthetic ion channels formed by macrocyclic bolaamphiphiles and rigidrod p-octiphenyl polyols .
Macrocyclic, branched and linear non-peptide bolaamphiphiles as staves:
Examples of this sub-class include synthetic ion channels formed by a.) macrocyclic, branched and linear bolaamphiphiles and dimeric steroids,  and by b.) non-peptide macrocycles, acyclic analogs and peptide macrocycles [respectively] containing abiotic amino acids .
Dimeric steroid staves:
Examples of this sub-class include channels using polydroxylated norcholentriol dimer .
pOligophenyls as staves in rigid rod b barrels:
Examples of this sub-class include “cylindrical self-assembly of rigid-rod b-barrel pores preorganized by the nonplanarity of p-octiphenyl staves in octapeptide-p-octiphenyl monomers” .
Examples of this sub-class include synthetic ion channels and pores comprised of a.) polyalanine, b.) polyisocyanates, c.) polyacrylates,  formed by i.) ionophoric, ii.) ‘smart’ and iii.) cationic polymers ; d.) surface-attached poly(vinyl-n-alkylpyridinium) ; e.) cationic oligo-polymers  and f.) poly(m-phenylene ethylenes) .
Helical b-peptides (used as staves in barrel-stave method):
Examples of this class include: a.) cationic b-peptides with antibiotic activity, presumably acting as amphiphilic helices that form micellar pores in anionic bilayer membranes .
Examples of this sub-class falling include synthetic carriers, channels and pores formed by monomeric steroids , synthetic cationic steroid antibiotics [that] may act by forming micellar pores in anionic membranes , neutral steroids as anion carriers  and supramolecular ion channels .
Complex minimalist systems:
Examples of this sub-class falling within the scope of this survey include ‘minimalist’ amphiphiles as synthetic ion channels and pores , membrane-active ‘smart’ double-chain amphiphiles, expected to form ‘micellar pores’ or self-assemble into ion channels in response to acid or light , and double-chain amphiphiles that may form ‘micellar pores’ at the boundary between photopolymerized and host bilayer domains and representative peptide conjugates that may self assemble into supramolecular pores or exhibit antibiotic activity .
Non-peptide macrocycles as hoops:
Examples of this sub-class falling within the scope of this survey include synthetic ion channels formed by non-peptide macrocycles acyclic analogs  and peptide macrocycles containing abiotic amino acids .
Peptide macrocycles as hoops and staves:
Examples of this sub-class include a.) synthetic ion channels formed by self-assembly of macrocyclic peptides into genuine barrel-hoop motifs that mimic the b-helix of gramicidin A with cyclic b-sheets. The macrocycles are designed to bind on top of channels and cationic antibiotics (and several analogs) are proposed to form micellar pores in anionic membranes ; b.) synthetic carriers, antibiotics (and analogs) and pores (and analogs) formed by macrocyclic peptides with non-natural subunits. [Certain] macrocycles may act as b-sheets, possibly as staves of b-barrel-like pores ; c.) bioengineered pores as sensors. Covalent capturing and fragmentations [have been] observed on the single-molecule level within engineered a-hemolysin pore containing an internal reactive thiol .
Thus even without knowledge of supramolecular or organic chemistry, one can see that a variety of alternate approaches to the creation of synthetic ion channels, and several sub-approaches within each larger ‘design motif’ or broad-approach, not only exist but have been experimentally verified, varietized and refined.
The following selections  illustrate the chemical, structural and functional varieties of synthetic ions categorized according to whether they are cation-conducting or anion-conducting, respectively. These examples are used to further emphasize the extent of the field, and the number of alternative approaches to synthetic ion-channel design, implementation, integration and experimental-verification already existent. Permission to use all the following selections and figures were obtained from the author of the source.
There are 6 classical design-motifs for synthetic ion-channels, categorized by structure, that are identified within the paper:
“The first non-peptidic artificial ion channel was reported by Kobuke et al. in 1992” .
“The channel contained “an amphiphilic ion pair consisting of oligoether-carboxylates and mono- (or di-) octadecylammoniumcations. The carboxylates formed the channel core and the cations formed the hydrophobic outer wall, which was embedded in the bilipid membrane with a channel length of about 24 to 30 Å. The resultant ion channel, formed from molecular self-assembly, is cation selective and voltage-dependent” .
“Later, Kokube et al. synthesized another channel comprising of resorcinol based cyclic tetramer as the building block. The resorcin--arenemonomer consisted of four long alkyl chains which aggregated to forma dimeric supramolecular structure resembling that of Gramicidin A” . “Gokel et al. had studied [a set of] simple yet fully functional ion channels known as “hydraphiles” .
“An example (channel 3) is shown in Figure 1.6, consisting of diaza-18-crown-6 crown ether groups and alkyl chain as side arms and spacers. Channel 3 is capable of transporting protons across the bilayer membrane” .
“A covalently bonded macrotetracycle4 (Figure 1.8) had shown to be about three times more active than Gokel’s ‘hydraphile’ channel, and its amide-containing analogue also showed enhanced activity” .
“Inorganic derivative using crown ethers have also been synthesized. Hall et. al synthesized an ion channel consisting of a ferrocene and 4 diaza-18-crown-6 linked by 2 dodecyl chains (Figure 1.9). The ion channel was redox-active as oxidation of the ferrocene caused the compound to switch to an inactive form” 
“These are more difficult to synthesize [in comparison to unimolecular varieties] because the channel formation usually involves self-assembly via non-covalent interactions” .“A cyclic peptide composed of even number of alternating D- and L-amino acids (Figure 1.10) was suggested to form barrel-hoop structure through backbone-backbone hydrogen bonds by De Santis” .
“A tubular nanotube synthesized by Ghadiri et al. consisting of cyclic D and L peptide subunits form a flat, ring-shaped conformation that stack through an extensive anti-parallel β-sheet-like hydrogen bonding interaction (Figure 1.11)” .
“Experimental results have shown that the channel can transport sodium and potassium ions. The channel can also be constructed by the use of direct covalent bonding between the sheets so as to increase the thermodynamic and kinetic stability” .
“By attaching peptides to the octiphenyl scaffold, a β-barrel can be formed via self-assembly through the formation of β-sheet structures between the peptide chains (Figure 1.13)” .
“The same scaffold was used by Matile etal. to mimic the structure of macrolide antibiotic amphotericin B. The channel synthesized was shown to transport cations across the membrane” .
“Attaching the electron-poor naphthalenediimide (NDIs) to the same octiphenyl scaffold led to the hoop-stave mismatch during self-assembly that results in a twisted and closed channel conformation (Figure 1.14). Adding the compleentary dialkoxynaphthalene (DAN) donor led to the cooperative interactions between NDI and DAN that favors the formation of barrel-stave ion channel.” .
“These aggregate channels are formed by amphotericin involving both sterols and antibiotics arranged in two half-channel sections within the membrane” .
“An active form of the compound is the bolaamphiphiles (two-headed amphiphiles). (Figure 1.15) shows an example that forms an active channel structure through dimerization or trimerization within the bilayer membrane. Electrochemical studies had shown that the monomer is inactive and the active form involves dimer or larger aggregates” .
ANION CONDUCTING CHANNELS:
“A highly active, anion selective, monomeric cyclodextrin-based ion channel was designed by Madhavan et al (Figure 1.16). Oligoether chains were attached to the primary face of the β-cyclodextrin head group via amide bonds. The hydrophobic oligoether chains were chosen because they are long enough to span the entire lipid bilayer. The channel was able to select “anions over cations” and “discriminate among halide anions in the order I-> Br-> Cl- (following Hofmeister series)” .
“The anion selectivity occurred via the ring of ammonium cations being positioned just beside the cyclodextrin head group, which helped to facilitate anion selectivity. Iodide ions were transported the fastest because the activation barrier to enter the hydrophobic channel core is lower for I- compared to either Br- or Cl-“ . “A more specific artificial anion selective ion channel was the chloride selective ion channel synthesized by Gokel. The building block involved a heptapeptide with Proline incorporated (Figure 1.17)” .
Cellular Prosthesis: Inklings of a New Interdisciplinary Approach
The paper cites “nanoreactors for catalysis and chemical or biological sensors” and “interdisciplinary uses as nano –filtration membrane, drug or gene delivery vehicles/transporters as well as channel-based antibiotics that may kill bacterial cells preferentially over mammalian cells” as some of the main applications of synthetic ion-channels , other than their normative use in elucidating cellular function and operation.
However, I argue that a whole interdisciplinary field and heretofore-unrecognized new approach or sub-field of Functionally-Restorative Medicine is possible through taking the technologies and techniques involved in in constructing, integrating, and experimentally-verifying either a.) non-biological analogues of ion-channels & ion-pumps (thus trans-membrane membrane proteins in general, also sometimes referred to as transport proteins or integral membrane proteins) and membranes (which include normative bilipid membranes, non-lipid membranes and chemically-augmented bilipid membranes), and b.) the artificial synthesis of biological analogues of ion-channels, ion-pumps and membranes, which are structurally and chemically equivalent to naturally-occurring biological components but which are synthesized artificially – and applying such technologies and techniques toward the purpose the gradual replacement of our existing biological neurons constituting our nervous systems – or at least those neuron-populations that comprise the neo- and prefrontal-cortex, and through iterative procedures of gradual replacement thereby achieving indefinite-longevity. There is still work to be done in determining the comparative advantages and disadvantages of various structural and functional (i.e. design) motifs, and in the logistics of implanting the iterative replacement or reconstitution of ion-channels, ion-pumps and sections of neuronal membrane in-vivo.
The conceptual schemes outlined in Concepts for Functional Replication of Biological Neurons , Gradual Neuron Replacement for the Preservation of Subjective-Continuity  and Wireless Synapses, Artificial Plasticity, and Neuromodulation  would constitute variations on the basic approach underlying this proposed, embryonic interdisciplinary field. Certain approaches within the fields of nanomedicine itself, particularly those approaches that constitute the functional emulation of existing cell-types, such as but not limited to Robert Freitas’s conceptual designs for the functional emulation of the red blood cell (a.k.a. erythrocytes, haematids) , i.e. the Resperocyte, itself should be seen as falling under the purview of this new approach, although not all approaches to Nanomedicine (diagnostics, drug-delivery and neuroelectronic interfacing) constitute the physical (i.e. electromechanical, kinetic and/or molecular physically-embodied) and functional emulation of biological cells.
The field of functionally-restorative medicine in general (and of nanomedicine in particular) and the field of supramolecular and organic chemistry converge here, where these technological, methodological, and experimental infrastructures developed in field of Synthetic Ion-Channels and Ion Channel Reconstitution can be employed to develop a new interdisciplinary approach that applies the logic of prosthesis to the cellular and cellular-component (i.e. sub-cellular) scale; same tools, new use. These techniques could be used to iteratively replace the components of our neurons as they degrade, or to replace them with more robust systems that are less susceptible to molecular degradation. Instead of repairing the cellular DNA, RNA and protein transcription and synthesis machinery, we bypass it completely by configuring and integrating the neuronal components (ion-channels, ion-pumps and sections of bilipid membrane) directly.
Thus I suggest that theoreticians of nanomedicine look to the large quantity of literature already developed in the emerging fields of synthetic ion-channels and membrane-reconstitution, towards the objective of adapting and applying existing technologies and methodologies to the new purpose of iterative maintenance, upkeep and/or replacement of cellular (and particularly neuronal) constituents with either non-biological analogues or artificially-synthesized-but-chemically/structurally-equivalent biological analogues.
This new sub-field of Synthetic Biology needs a name to differentiate it from the other approaches to Functionally-Restorative Medicine. I suggest the designation ‘cellular prosthesis’.
 Williams (1994)., An introduction to the methods available for ion channel reconstitution. in D.C Ogden Microelectrode techniques, The Plymouth workshop edition, CambridgeCompany of Biologists.
 Tomich, J., Montal, M. (1996). U.S Patent No. 5,16,890. Washington, DC: U.S. Patent and Trademark Office.
 Matile, S., Som, A., & Sorde, N. (2004). Recent synthetic ion channels and pores. Tetrahedron, 60(31), 6405-6435. ISSN 0040-4020, 10.1016/j.tet.2004.05.052. Access: http://www.sciencedirect.com/science/article/pii/S0040402004007690:
 XIAO, F., (2009). Synthesis and structural investigations of pyridine-based aromatic foldamers.
 Ibid., p. 6411.
 Ibid., p. 6416.
 Ibid., p. 6413.
 Ibid., p. 6412.
 Ibid., p. 6414.
 Ibid., p. 6425.
 Ibid., p. 6427.
 Ibid., p. 6416.
 Ibid., p. 6419.
 Ibid., p. 6419.
 Ibid., p. 6419.
 Ibid., p. 6419.
 Ibid., p. 6419.
 Ibid., p. 6421.
 Ibid., p. 6422.
 Ibid., p. 6422.
 Ibid., p. 6422.
 Ibid., p. 6422.
 Ibid., p. 6423.
 Ibid., p. 6423.
 Ibid., p. 6423.
 Ibid., p. 6426.
 Ibid., p. 6426.
 Ibid., p. 6427.
 Ibid., p. 6327.
 Ibid., p. 6427.
 XIAO, F. (2009). Synthesis and structural investigations of pyridine-based aromatic foldamers.
 Freitas Jr., R., (1998). “Exploratory Design in Medical Nanotechnology: A Mechanical Artificial Red Cell”. Artificial Cells, Blood Substitutes, and Immobil. Biotech. (26): 411–430. Access: http://www.ncbi.nlm.nih.gov/pubmed/9663339
It is often said that empiricism is one of the most useful concepts in epistemology. Empiricism emphasises the role of experience acquired through one’s own senses and perceptions, and is contrary to, say, idealism where concepts are not derived from experience, but based on ideals.
In the case of radical life extension, there is a tendency to an ‘idealistic trance’ where people blindly expect practical biotechnological developments to be available and applied to the public at large within a few years. More importantly, idealists expect these treatments or therapies to actually be effective and to have a direct and measurable effect upon radical life extension. Here, by ‘radical life extension’ I refer not to healthy longevity (a healthy life until the age of 100–120 years) but to an indefinite lifespan where the rate of age-related mortality is trivial.
Let me mention two empirical examples based on experience and facts:
1. When a technological development depends on technology alone, its progress is often dramatic and exponential.
2. When a technological development also depends on biology, its progress is embarrassingly negligible.
Developments based solely on mechanical, digital or electronic concepts are proliferating freely and vigorously. Just 20 years ago, almost nobody had a mobile telephone or knew about the internet. Now we have instant global communication accessible by any member of the general public.
Contrast this with the advancement of biotechnology with regards to, say, the treatment of the common cold. There has not been a significantly effective treatment for the public at large for, I will not say a million, but certainly for several thousand years. The accepted current medical treatment for the common cold is with bed rest, fluids, and antipyretics which is the same as that suggested by Hippocrates. Formal guidelines for the modern treatment of cardiac arrest include chest compressions and mouth- to- mouth resuscitation (essentially the same as the technique used by the prophet Elisha in the Old Testament) as well as intra-cardiac (!) atropine, lignocaine and other drugs used by physicians during the 1930’s. In my medical museum in Cyprus (http://en.wikipedia.org/wiki/Kyriazis_Medical_Museum) I have examples of Medieval treatments for urinary retention (it was via a metal urinary catheter then, whereas now the catheter is plastic), treatment of asthma (with belladonna then, ipratropium now – a direct derivative), and treatment of pain (with opium then, with opium-like derivatives now).
About a hundred years ago, my grandfather (http://en.wikipedia.org/wiki/Neoklis_Kyriazis) wrote a book on hygiene, longevity and healthy life for the public, which included advice such as fresh air, exercise, consumption of fruit and vegetables, avoidance of excessive alcohol or cigarette smoke. These are of course preventative treatments advised by modern anti-ageing practitioners, hardly any progress in a century. In fact, these are the only proven treatments. Even the modern notion of ‘antioxidants’ can be encountered as standard health advice in medical books from the 1800’s. With the trivial exception of a handful of other examples, there has hardly been any progress in healthy longevity at all that can be applied to the common man in the street. Resveratrol? Was a standard health advice in ancient Greek medicine (red wine). Carnosine? Discovered and used 100 years ago. Cycloastragenol? Used in Chinese medicine 1000 years ago.
My question is: how do we expect to influence the process of ageing when we cannot even develop bio-technological cures for simple and common diseases? Are we really serious when we talk about biotechnological treatments that can lead to radical life extension, being developed within the next few years? And if we are really serious, is this belief based on empiricism or idealism? The manipulation of human biology has been particularly tricky, with no significant progress of effective breakthroughs developed during the past several decades. Here I, of course, acknowledge the value of some modern drugs and isolated bio-technological achievements, but my point is that these developments are based on relatively minor refinements of existing therapies, and not on new breakthroughs that can modify the human body in any positive or practical degree. Importantly, even if some isolated examples of effective biotechnology do exist, these are not yet suitable for use by the general public at large.
If we were to compare the progress of general technology with that of life extension biotechnology, we could see that:
A. The progress of technology over the past 100 years has been logarithmic to exponential, whereas that of life extension biotechnology has been virtually static.
B. The progress of technology over the past 20 years has been exponential, whereas that of life extension biotechnology has barely been logarithmic.
It is one thing to talk about future biotechnology developments as a discussion point, and to post these in blogs, for general curiosity. But it is a different thing altogether if we actually want to devise and deliver an effective, practical therapy that truly affords significant life extension.
A different approach is needed, one that does not depend exclusively on biotechnology. It would be naïve to say that I am arguing for the total abandonment of life extension biotechnology, but it is equally naïve to believe that this biotechnology is likely to be effective on its own. A possible way forward could be the attempt to modify human biology not via biotechnology alone, but also by making use of natural, already existing evolutionary mechanisms. One such example could be the use of ‘information-that-requires-action’ in order to force a reallocation of resources from germ-line to somatic cells. This is an approach we currently aiming to describe in detail. My final remark with regards to achieving indefinite lifespan is this: we must engage with technology without depending on biotechnology.
For some general background information on how to engage with technology see: